Atorvastatin 80mg
Atorvastatin 80mg is a pharmaceutical drug with 21 clinical trials. Currently 3 active trials ongoing. Historical success rate of 90.9%.
Success Metrics
Based on 10 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
6
Mid Stage
9
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
83.3%
10 of 12 finished
16.7%
2 ended early
3
trials recruiting
21
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Combined Effects of Statins and Exercise on Training Sensitive Health Markers
Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD
Atorvastatin Efficacy and Safety in Patients With Ulcerative Colitis
Atorvastatin in Patients With Ulcerative Colitis
The Effect of Atorvastatin 80 mg on Hs-CRP/Albumin Ratio in Reducing Thrombus Burden in PCI-STEMI Patients
Clinical Trials (21)
Combined Effects of Statins and Exercise on Training Sensitive Health Markers
Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD
Atorvastatin Efficacy and Safety in Patients With Ulcerative Colitis
Atorvastatin in Patients With Ulcerative Colitis
The Effect of Atorvastatin 80 mg on Hs-CRP/Albumin Ratio in Reducing Thrombus Burden in PCI-STEMI Patients
Clinical Study to Evaluate the Possible Efficacy of Dapagliflozin and Atorvastatin in Patients With Major Depressive Disorders
Statin Therapy With Atorvastatin in Surgical Aortic Valve Replacement
Ameliorating Contrast Induced Nephropathy After Coronary Angiography
Assessment of the Effects of Long-term Lipid-lowering Therapy in Patients With Primary STEMI or NSTEMI
Evaluation of the Effect of Long-term Lipid-lowering Therapy in STEMI Patients With Coronavirus Infection COVID-19
Neoadjuvant Zoledronate and Atorvastatin in Triple Negative Breast Cancer
High-Dose Atorvastatin for Vascular Wall Protection in Thrombectomy Patients
Study of the Therapeutic Effect of Atorvastatin on the Clinical Outcomes in HER2 Negative Breast Cancer Patients"
Impact of Atorvastatin on Prostate Cancer Progression During ADT
Effect of Statin Preloading in STEMI in Improving PCI Outcomes
A Study to Determine the Bioequivalence of SCH 900068 Compared to Marketed Products (Protocol No. P07551)
Atorvastatin For The Reduction Of Ventricular Arrhythmias
Early Alirocumab to Reduce LDL-C in Myocardial Infarction
Effect of 80-mg Atorvastatin on Myocardial Edema
Effects of Atorvastatin on Myonecrosis
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 21